Vicarious Surgical Inc. RBOT
0.10
0.05
100.00%
as of 25 Sep
- Market cap
- $14.3M
- P/E
- 0.0×
Follow RBOT
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '17 | |
|---|---|---|---|---|---|---|---|---|
Current Ratio |
2.97 | 6.74 | 13.87 | 14.35 | 28.56 | 21.04 | — | — |
Net Debt/EBITDA |
0.20 | 0.76 | 1.25 | 1.27 | 4.55 | 1.31 | — | — |
Debt/Assets |
0.00% | 0.00% | 0.00% | 11.18% | 0.70% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.14 | 0.02 | 0.00 | — | — |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Operating CF/Net income |
0.90 | 0.79 | 0.88 | (11.87) | 0.95 | 0.94 | — | — |
Capex/Depreciation |
(0.09) | (0.09) | (0.90) | (4.51) | (3.82) | (0.76) | — | — |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — |
| (177.51%) | (87.40%) | (68.01%) | 5.31% | (70.45%) | (29.23%) | — | — | |
| (114.96%) | (67.41%) | (54.64%) | 3.20% | (35.30%) | (144.76%) | 0.00% | — | |
ROIC |
(63,809.95%) | 0.00% | 0.00% | (475.61%) | 0.00% | 0.00% | — | — |
Return on Tangible Assets |
(560.82%) | (130.34%) | (71.02%) | 4.35% | (20.19%) | (76.84%) | — | — |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | — | — |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | — | — |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | — | — |
Free Cash Flow per Share |
(7.37) | (8.52) | (13.14) | (16.41) | (10.74) | (4.64) | — | — |
Cash per Share |
1.60 | 8.34 | 20.17 | 28.65 | 53.89 | 6.43 | — | — |
Shareholders Equity per Share |
1.61 | 7.93 | 20.13 | 27.38 | 25.81 | 6.43 | — | — |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — |
Book value per Share |
1.61 | 7.93 | 20.13 | 27.38 | 25.81 | 6.43 | — | — |
Free Cash Flow |
(45.21) | (50.14) | (63.97) | (66.56) | (34.59) | (12.16) | — | — |
Working Capital |
7.68 | 44.03 | 93.67 | 112.01 | 172.13 | 16.31 | — | — |
Capital Expenditures |
(0.13) | (0.18) | (1.67) | (5.35) | (1.29) | (0.12) | — | — |
Net Current Asset Value |
1.84 | 30.68 | 79.06 | 91.16 | 79.79 | 16.19 | — | — |
| Other line items | ||||||||
Quick Ratio |
2.51 | 6.40 | 13.49 | 13.85 | 27.78 | 20.72 | — | — |
Depreciation/Fixed assets |
1.12 | 0.47 | 0.29 | 0.18 | 0.15 | 0.35 | — | — |
Cash ROIC |
(236.05%) | (56.82%) | (35.03%) | (27.91%) | (13.79%) | (37.02%) | — | — |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — |
Inventory Turnover |
— | — | — | 0.00 | 0.00 | — | — | — |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — |
Days of Inventory on Hand |
— | — | — | 0.00 | 0.00 | — | — | — |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — |
Operating CF per Share |
(7.35) | (8.49) | (12.80) | (15.09) | (10.34) | (4.59) | — | — |
Capex per Share |
(0.02) | (0.03) | (0.34) | (1.32) | (0.40) | (0.05) | — | — |
Average Payables |
1.03 | 1.21 | 1.49 | 1.62 | 0.94 | 0.76 | — | — |
Average Assets |
43.65 | 93.79 | 130.08 | 160.99 | 99.73 | 8.89 | 0.00 | — |
Average Common Equity |
28.27 | 72.33 | 104.51 | 97.07 | 49.97 | 44.05 | — | — |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | — | — |
Columns are period end dates